Compare ANIX & OESX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIX | OESX |
|---|---|---|
| Founded | 1982 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Products |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 103.4M |
| IPO Year | 2013 | 2007 |
| Metric | ANIX | OESX |
|---|---|---|
| Price | $2.74 | $28.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $8.67 | ★ $17.50 |
| AVG Volume (30 Days) | ★ 365.4K | 98.0K |
| Earning Date | 05-27-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.82 | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | $210,000.00 | ★ $86,306,000.00 |
| Revenue This Year | N/A | $7.94 |
| Revenue Next Year | N/A | $13.89 |
| P/E Ratio | ★ N/A | $61.79 |
| Revenue Growth | N/A | ★ 8.26 |
| 52 Week Low | $2.32 | $7.88 |
| 52 Week High | $5.46 | $31.00 |
| Indicator | ANIX | OESX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 63.59 |
| Support Level | N/A | $8.98 |
| Resistance Level | N/A | $31.00 |
| Average True Range (ATR) | 0.00 | 2.31 |
| MACD | 0.00 | -0.17 |
| Stochastic Oscillator | 0.00 | 76.11 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.